SWISS_CLEARANCE - Compartment Compressibility Monitoring Using CPM#1

NCT05483946 | Completed

• 1 other identifier: SWISS_CLEARANCE
• Study Type: interventional
• Target: 7
• Locations: 1 country
• Sites: 1

Brief Summary

Compartment syndrome is a very serious musculoskeletal disorder, which can lead to potentially devastating consequences, such as limb amputation and life- threatening conditions. It is a well described medical condition considered to be an orthopaedic emergency affecting all ages. Even though compartment syndrome is a well described medical condition, the appropriate treatment (i.e., fasciotomy to release tissue pressure) is invasive and involves its own risks. Furthermore, and of most critical importance is the timing for the intervention of a fasciotomy. The concerned limb may already have had severe, sometimes even irreversible, tissue damage due to high intra- compartmental pressure within 6 to 10 hours. The standard diagnostic method for compartment syndrome is an invasive intra-compartmental pressure measurement via insertion of a pressure monitoring device into the muscle compartment. Commercially available intra compartmental pressure monitors have a highly variable intra-observer reproducibility and user errors are common. Compared to the invasive modalities, the Compremium Compartmental Compressibility Monitoring System (CPM#1) shows promising advantages for the clinical application. Not only is the technology used for the CPM#1 device safe and non-invasive for the patient with only initial training required for the healthcare professionals, but it has also demonstrated high intra- and inter- observer reproducibility (as per bench tests and clinical settings with prototypes, to be confirmed in clinical studies like this one). The use of the CPM#1 device therefore facilitates the measurements, as it is based on pre-existing ultrasound methods and avoids any further risks to the patients compared to invasive compartmental pressure diagnosis methods.

Conditions

Compartment Syndromes

Outcome Measures

Primary Outcomes (1)

• Inter-operator reproducibility with 3 raters

  Inter-operator reproducibility will be assessed using intra-class correlation coefficients (two-way random effects, single rater, absolute agreement). Three independent raters will conduct 4 measurements per compartment site on 14 relaxed forearms (7 volunteers, 1 site per forearm), and 14 relaxed legs (7 volunteers, 2 sites per leg).

  During the procedure which should last about 3 hours/patient

Secondary Outcomes (2)

• Intra-operator reproducibility

  During the procedure which should last about 3 hours/patient

• Validation of number of measurement repetitions

  During the procedure which should last about 3 hours/patient

Other Outcomes (2)

• Assessment of adverse events and serious adverse events

  During the procedure which should last about 3 hours/patient

• Assessment of device deficiencies

  During the procedure which should last about 3 hours/patient

Study Arms (1)

CPM#1

EXPERIMENTAL

Compartment compressibility ratio measurement using the CPM#1 device

Device: Measurement of compartment compressibility

Interventions

Measurement of compartment compressibility DEVICE

Application of the CPM#1 device for compartment compressibility ratio measurement - for each participant, a pre-defined number of measurements will be conducted per leg and forearm

CPM#1

Eligibility Criteria

• Age: 18 Years - 84 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Healthy volunteer
• Male or female
• Age 18 to 84 years

You may not qualify if:

• Previous surgery to or fracture of the leg and/or forearm
• Peripheral arterial or venous disease
• History of compartment syndrome
• Limb anomalies
• General muscle disorder

Sponsors & Collaborators

• Compremium AG: lead

Study Sites (1)

Universitäres Notfallzentrum, Inselspital Bern

Bern, 3010, Switzerland

Location

MeSH Terms

Conditions

Compartment Syndromes

Condition Hierarchy (Ancestors)

Muscular Diseases; Musculoskeletal Diseases; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Beat Lehmann

  Universitäres Notfallzentrum, Inselspital Bern

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Masking Details: Investigators will be blinded to the measurement results
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 28, 2022
• First Posted: August 2, 2022
• Study Start: November 1, 2022
• Primary Completion: November 1, 2022
• Study Completion: November 1, 2022
• Last Updated: November 8, 2022

Record last verified: 2022-11

Data Sharing

• IPD Sharing: Will not share

Locations

CH (1)